People · Operator
Named in public records as an officer, director or promoter · active 2011–2021 · Biotechnology, Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Arbor Biotechnologies, Inc. | — | Biotechnology | Series D+ | $230.6M | $5.7B | 2021 |
| LARQ, Inc. | — | Other | Series A | $9.8M | $96.1M | 2019 |
| Social Rewards, Inc. | — | Other Technology | Seed | $1.6M | $34.4M | 2011 |
David Cheng at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Cheng on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Murphy | 1 | 17 |
| Paul Meister | 1 | 12 |
| Keith Crandell | 1 | 11 |
| Chen Yu | 1 | 7 |
| David Walt | 1 | 6 |
| David R. Walt | 1 | 5 |
| Mark Angelino | 1 | 4 |
| Kelly Morgan | 1 | 2 |
| Michael Liao | 1 | 2 |
| ANNIE XIA HAZLEHURST | 1 | 1 |
| FENG R. ZHANG | 1 | 1 |
| Justin Wang | 1 | 1 |
| Douglas Collins | 1 | 1 |
| Amanda Chaperot | 1 | 1 |
| Robert C. Walker | 1 | 1 |
| Dipender C. Saluja | 1 | 1 |
| Michael C. Liao | 1 | 1 |
| David C. Cheng | 1 | 1 |
| Douglas C. Collins | 1 | 1 |
| Joseph Morin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.